Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases.
CONMED is a global medical technology company that specializes in the development and sale of products and services that allow physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. With products that are recognized as technological leaders by the specialties they serve, caregivers within the Arthroscopy, Electrosurgery, Endoscopy, EndoSurgery, Gastroenterology, Integrated Systems, Patient Care, Powered Surgical Instruments and Pulmonology markets have come to value the CONMED name across the world. CONMED’s family of business units are able to focus on the needs and wants of specific specialties while coming together at the point of care delivery to offer customers the power of choice and the power of convenience.
PhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country’s leading innovative biopharmaceutical research companies. Our members are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. New medicines are an integral part of the health care system, providing doctors and patients with safe and effective treatment options, and improving quality of life.